Sci. Signal., 14 April 2009
Cancer The Enzymology of Brain Cancer
Paula A. Kiberstis
Science, AAAS, Washington, DC 20005, USA
Many human gliomas (a type of brain tumor) harbor somatic mutations in two genes encoding isocitrate dehydrogenases (IDHs). By structural modeling and biochemical analyses, Zhao et al. show that tumor-associated mutations in IDH1 lead to a loss of enzyme activity in a dominant manner through the formation of catalytically inactive heterodimers. Expression of mutant IDH1 reduces formation of the enzyme product -ketoglutarate and enhances the expression of hypoxia-inducible factor 1 (HIF-1), a subunit of a transcription factor that helps cells to survive and grow when oxygen levels are low. Thus, the IDH1 gene is likely to function as a tumor suppressor that, when inactivated by mutation, facilitates tumor growth through effects on the HIF-1 pathway.
S. Zhao, Y. Lin, W. Xu, W. Jiang, Z. Zha, P. Wang, W. Yu, Z. Li, L. Gong, Y. Peng, J. Ding, Q. Lei, K.-L. Guan, Y. Xiong, Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1. Science 324, 261–265 (2009). [Abstract] [Full Text]
Citation: P. A. Kiberstis, The Enzymology of Brain Cancer. Sci. Signal. 2, ec133 (2009).
The editors suggest the following Related Resources on Science sites:
In Science Signaling
Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882